Xilin Yang Professor
Department of Epidemiology and Biostatistics
Email:yangxilin@
Resume
Research direction
Professor Xilin Yang obtained his PhD degree in epidemiology from the University of Melbourne, Australia in 2002; and completed postdoctoral training and worked as a diabetes epidemiologist at the Chinese University of Hong Kong Faculty of Medicine and presently employed by Tianjin Medical University School of Public Health as professor and head of Department of Epidemiology and Biostatistics.
Major research interests are epidemiology of type 2 diabetes and gestational diabetes mellitus (GDM), with a special interest in prevention of GDM and its adverse outcomes. He and coworkers set up the screening and management system for GDM in Tianjin, China in 2000, as the result of “Tianjin Study of Diabetes in Pregnancy” and conducted two translational studies in this population (as a principle investigator and co-investigator), “A Randomized Trial of Effects of Translation of Intervention of Gestational Diabetes into the Three Level-Prenatal Care Network in Tianjin, China” to examine the effectiveness and cost-effectiveness of lifestyle intervention during pregnancy on the pregnancy outcomes of women with GDM; and “Tianjin Gestational Diabetes Prevention Program” to examine the effect of lifestyle intervention at postpartum on the risk of diabetes among women with prior GDM.
Education
2000-2002 | Doctor of Philosophy (in Epidemiology),Department of Rural Health, the University of Melbourne, Victoria, Australia; Thesis title: Tianjin Study of Diabetes in Pregnancy |
1998-2000 | Doctor of Philosophy Candidate (in Epidemiology),Department ofMedicine (and later transferred to Department of Community Medicine and General Practice) |
1988-1991 | Master of Engineering (in Food Nutrition), Department of Food Engineering, Tianjin Institute of Light Industry, Hexi District, Tianjin, China (Renamed as Tianjin University of Science and Technology); Thesis title: Social Nutro-Economic Surveillance: Its Application and Practice |
1980-1983 | Diploma of Medicine (a three year training program), |
Professional Experience
2011Nov– | Professor & Director, Department of Epidemiology & Biostatistics, |
2007Mar–2011 Oct | Research Assistant Professor, Department of Medicine and Therapeutics,the |
2005 Mar–2007 Feb | Post-Doctoral Fellow, Department of Medicine and Therapeutics,the Chinese University of Hong Kong, Hong Kong SAR, China |
2003 Feb- 2005 Feb | Research Associate, Centre for Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong SAR, China |
2001 Nov- 2002 Dec | Research Analyst, Chinese Health Foundation of Australia (CHFA), |
2000 Oct-2001 Oct | Research Analyst (part time: 0.5), Chinese Health Foundation of Australia, |
1997 Feb-1998 Jan | Visiting Research Fellow, Monash University Department of Medicine, |
1994 Jun – 1997 Jan | Nutritionist in Charge, Tianjin Institute of Food Safety Control and Inspection Nutrition Department, |
1991 Jun – 1994 May | Nutritionist, Tianjin Institute of Food Safety Control and Inspection Nutrition Department, |
1985 May-1988 Aug | Junior Clinical Doctor, Yuci Municipal Hospital Department of Pediatrics & Department of Internal Medicine, Yuci, Shanxi, PR China (Renamed as Yuci People’s Hospital) |
1983 Aug-1985 Apr | Junior Clinical Doctor, Xincheng County Hospital Department of Internal Medicine, |
Project
2019- | National Natural Science Foundation of China (General Research Project): Principal Investigator, Title: The roles of the cross-talk between gut microbe and bile acids in the mechanism of gestational diabetes mellitus. Ref. number：81870549; RMB￥ 570,000; 01/01/2019-31/12/2022. |
2018- | National Key Research and Development Program of China:Principal Investigator, Title: Current profile of risk factor prevalence of gestational diabetes mellitus and its risk prediction model and intervention and management technique development. Ref. number: 2018YFC1313903; RMB￥ 2,150,000; 09/01/2018-31/12/2020. |
2018- | The Chines University of Hong Kong： Collaborative Analysis of GWAS data (Ref number: TT17114918), Principle Investigator, RMB100,000, 01/01/2018-31/12/2023. |
2013- | European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Program for Collaborative Research between China and Europe，€170,000 – Co-I (PI: Huiguang Tian/Gang Hu) “Tianjin gestational diabetes prevention program follow-up study”, From 01/07/2013 to 31/12/2019. |
2012- | Tianjin Medical University, Seeding G rant, CNY Yuan 300,000 – Principal Investigator, “A pilot trial of prevention of liver cancer among patients with Type 2 diabetes and Hepatitis B Virus Infection”. |
2010- | Hong Kong Research G rant Council Direct Allocation, HKD$32,000 – Principal Investigator; Project title: “Impacts of hyperglycaemia and insulin treatment on the insulin-like growth factor pathway for cancer in Type 2 diabetes” (Ref No. 2009.2.010) (from |
2010- | International Diabetes Federation (IDF) and Lilly’s Bringing Research In Diabetes to Global Environments and Systems (BRiDGES), US$393,812 – Co-Principal Investigator (with Huiguang Tian); Project title: “A randomized translational study to examine the effects of shared care versus usual care in management of gestational diabetes in a three-tier prenatal care network in Tianjin, China” (Ref No. LT09-227) (01/07/2010 to 31/12/2013) |
2009- | European Foundation for the Study of Diabetes (EFSD) and the Chinese Diabetes Society (CDS) and Lilly Research G rant, Euro 200,000 – Project Advisor (PI: Huiguang Tian & Jaakko Tuomilehto& Gang Hu); Project title: “A Study of the Interaction of Lifestyle and Genetic Factors on the Incidence of Type 2 Diabetes in Tianjin Women with Gestational Diabetes” (01/07/2009 to 31/12/2013) |
2009- | Hong Kong Research G rant Council Direct Allocation, HKD$50,000 – Principal Investigator; Project title: “Use of oral anti-diabetic drugs and risks of cancer in type 2 diabetes” (Ref No. 2008.1.043) (from |
2009- | Food and Health Bureau, |
2008- | |
2007-
| Hong Kong Research G rant Council (Earmarked Grant), HKD$ 758,340 – Co-Investigator (PI: Alice P Kong); Project title: “Sleep duration, neurohormonal dysregulation and obesity in |
1999-2001 | Tianjin Scientific and Technical Committee, RMB Y48,000 – Co-investigator; Project title: Study on the effect of Intensive Management on Perinatal Morbidity in Women with IGT in Pregnancy, a component of Tianjin Study of Diabetes in Pregnancy. |
Publications in recent five years
1.Huo X#, Li J#, Cao YF, Li SN, Shao P, Leng J, Li W, Liu J, Yang K, Ma RCW, Hu G, Fang ZZ*, Yang X*. Trimethylamine-N-oxide metabolites in the early pregnancy and risk of gestational diabetes: a nested case control study. J Clin Endocrinol Metab. 2019 Aug 2. pii: jc.2019-00710. doi: 10.1210/jc.2019-00710. (2-y IF: 5.605, 5-y IF: 5.960)
2.Yang W#, Liu J#, Li J, Liu J, Liu H, Wang Y, Leng J, Wang S, Chen H, Chan JCN, Yu Z, Hu G, Yang X*. Interactive effects of prepregnancy overweight and gestational diabetes on macrosomia and large for gestational age: A population-based prospective cohort in Tianjin, China. Diabetes Res Clin Pract. 2019 Aug;154:82-89. doi: 10.1016/j.diabres.2019.06.014. (2-y IF: 3.239; 5-y IF: 3.587)
3.Cao YF#, Li J#, Zhang Z#, Liu J, Sun XY, Feng XF, Luo HH, Yang W, Li SN, Yang X*, Fang ZZ*. Plasma Levels of Amino Acids Related to Urea Cycle and Risk of Type 2 Diabetes Mellitus in Chinese Adults. Front Endocrinol (Lausanne). 2019 Feb 18;10:50. doi: 10.3389/fendo.2019.00050. eCollection 2019.(2-y IF: 3.643).
4.Ren Y#, Gao L#, Guo X, Huo X, Lu J, Li J, Ji L*, Yang X*.Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China.J Diabetes Complications. 2018 Nov;32(11):1000-1005. doi: 10.1016/j.jdiacomp.2018.09.002. Epub 2018 Sep 7. (2-y IF: 2.792; 5-y IF: 3.094)
5.Liu J, Liu E, Leng J, Pan L, Zhang C, Li W, Li J, Huo X, Chan JCN, Yu Z, Hu G, Yang X.Indicators of socio-economic status and risk of gestational diabetes mellitus in pregnant women in urban Tianjin, China.Diabetes Res Clin Pract. 2018 Sep 8;144:192-199. doi: 10.1016/j.diabres.2018.08.023. [Epub ahead of print] (2-y IF: 3.239; 5-y IF: 3.587)
6.Li J, Huo X, Cao YF, Li SN, Du Z, Shao P, Leng J, Zhang C, Sun XY, Ma RCW, Fang ZZ*, Yang X*. Bile acid metabolites in early pregnancy and risk of gestational diabetes in Chinese women: A nested case-control study. EBioMedicine. 2018 Sep;35:317-324. doi: 10.1016/j.ebiom.2018.08.015. Epub 2018 Aug 14. (2-y IF: 6.183; 5-y IF:6.112).
7.Li J#, Leng J#, Li W, Zhang C, Feng L, Wang P, Chan JCN, Hu G, Yu Z, Yang X*. Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes. 2018 December; 12(6):565-573. doi: 10.1016/j.pcd.2018.07.010.(2-y IF: 2.008; 5-y IF: 1.975).
8.Li J#, Cao YF#, Sun XY, Han L, Li SN, Gu WQ, Song M, Jiang CT, Yang X*, Fang ZZ*. Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in Chinese. J Diabetes Investig. 2019 Mar;10(2):491-498. doi: 10.1111/jdi.12898. (2-y IF: 3.902; 5-y IF: 3.641).
9.Li J#, Wang P#, Zhang C, Leng J, Li N, Wang L, Li W, Liu H, Yu Z, Hu G, Chan JCN, Yang X*. Short body height and pre-pregnancy overweight for increased risk of gestational diabetes mellitus: A population-based cohort study. Front Endocrinol (Lausanne). 2018 Jun 26;9:349. doi: 10.3389/fendo.2018.00349. eCollection 2018. (2-y IF: 3.643).
10.Lyu Y#, Luo Y#, Li C, Guo X, Lu J, Wu H, Huo X, Gu W, Yang G, Ji L*, Yang X*.Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China. J Clin Endocrinol Metab.2018 Sept; 103(9): 3319-3330doi.org/10.1210/jc.2018-00422 (2-y IF: 5.605, 5-y IF: 5.960)
11.Song C#, Li W#, Leng J, Wang L, Li W, Shi F, Liu G, Zhou J, Yang X*. Passive smoking and postpartum depression among Chinesewomen: a prospective cohort study in Tianjin, China. WomenHealth. 2018 Jun 20:1-13. doi: 10.1080/03630242.2018.1478365. [Epub ahead of print](2-y IF: 1.437; 5-y IF: 1.746)
12.Li J#, Song C, Li C, Liu P, Sun Z, Yang X*.Increased risk of cardiovascular disease in women with prior gestational diabetes: A systematic review and meta-analysis.DiabetesRes Clin Pract. 2018 Apr 12;140:324-338. doi: 10.1016/j.diabres.2018.03.054. (2-y IF: 3.239; 5-y IF: 3.587)
13.Huo X#, Zhang J#, Guo X, Lu J, Li J, Zhao W, Ji L*, Yang X*.Gender difference in the association of early- vs. late-onset type 2 diabetes with non-fatal microvascular disease in China: A cross-sectional study.Front Endocrinol (Lausanne). 2018 Jan 31;9:15. doi: 10.3389/fendo.2018.00015. eCollection 2018. (2-y IF: 3.643).
14.Song C#, Lyu Y#, Li C, Liu P, Li J, Ma RC,Yang X*.Long-term risk ofdiabetesin women at varying durations after gestationaldiabetes: a systematic review and meta-analysis with more than 2 million women.Obes Rev. 2018 Mar;19(3):421-429. doi: 10.1111/obr.12645. (PMID: 29266655; 2-y IF: 8.192; 5-y IF:10.179).
15.Ren Y#, Ren Q#, Lu J, Guo X, Huo X,Ji L*,Yang X*.Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2diabetes: a cross sectional survey in China.Diabetes Metab Res Rev. 2018 Feb;34(2):e2960. doi: 10.1002/dmrr.2960.(2-y IF: 4.758; 5-y IF:4.105)
16.Li J#, Luo Y#, Guo X, Huo X, Lu J, Ren Y, Ji L*, Yang X*. Long exposure to type 2 diabetes and risk of non-fatalcoronaryheartdiseaseinChinese femalesand males:findings from a China national cross-sectional study. Diabetes Res Clin Pract. 2018 Mar;137:119-127. doi: 10.1016/j.diabres.2017.10.025.(2-y IF: 3.239; 5-y IF: 3.587)
17.Han Q#, Shao P#,Leng J, Zhang C, Li W, Liu G, Zhang Y, Li Y, Li Z, Ren Y, Chan JC,Yang X*.Interactions between general and central obesity in predicting gestational diabetes mellitus in Chinese pregnant women: A prospective population-based study in Tianjin, China.J Diabetes. 2018 Jan;10(1):59-67. doi: 10.1111/1753-0407.12558. Epub 2017 May 30.(2-y IF: 3.298; 5-y IF: 2.892).
18.Song C#,Leng J#,Wang L,Li W,Zhang S,Wang W,Liu P,Zhang J,Xie B,Li W,Chan JCN,Yang X*. ABO blood types and postpartumdepressionamong Chinese women: A prospective cohort study in Tianjin, China.Women Health.2017 May 22:1-14. doi: 10.1080/03630242.2017.1333077. (2-y IF: 1.437; 5-y IF: 1.746)
19.Leng J#, Wang P, Shao P, Zhang C, Li W, Li N, Wang L, Nan H, Yu Z, Hu G, Chan JC, Yang X*. Passive smoking increased risk of gestational diabetes mellitus independently and synergistically with pre-pregnancy obesity in Tianjin, China. Diabetes Metab Res Rev.2017 Mar;33(3):e2861. doi: 10.1002/dmrr.2861. (2-y IF: 3.904; 5-y IF: 3.761)
20.Wang H#, Leng J, Li WQ, Wang L, Zhang C, Li W, Liu H, Zhang S, Chan J, Hu G, Yu Z, Yang X*. Sleep duration and quality, and risk of gestational diabetes mellitus in pregnant Chinese women. Diabet Med.2017 Jan;34(1):44-50. doi: 10.1111/dme.13155 (2-y IF: 3.132; 5-y IF: 3.401).
21.Song T#,Luo Y#, Wang X, Li J, Han Q, Zhu H, Zhao W,Li W, Sun Z*,Yang X*. Clinical characteristics of Chinese with over 40 years of duration of type 2 diabetes. J Diabetes. 2017 Jan;9(1):45-52. doi: 10.1111/1753-0407.12375. (2-y IF: 3.213; 5-y IF: 2.764).
22.Ren Y#, Jin N#, Hong T, Mu Y, Guo L, Ji Q, Li Q,Yang X*, Ji L*.Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes. Sci Rep. 2016 Nov 2;6:36437. doi: 10.1038/srep36437.(2-y IF: 4.259; 5-y IF: 4.847).
23.Song C#, Li J, Leng J, Ma RW, Yang X*. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes Rev.2016 Oct;17(10):960-9.doi: 10.1111/obr.12442.(2-y IF: 7.883; 5-y IF: 9.025).
24.Ren Y#, Ji L#, Mu Y, Hong T*, Ji Q, Guo L, Huang Q, Yang X*. Uric acid, renal function and risk of hypoglycemia in Chinese type 2 diabetes patients. DiabetesMetab Res Rev.2016 Nov;32(8):875-882. doi: 10.1002/dmrr.2809. (2-y IF: 3.263; 5-y IF: 3.550)
25.Leng J#, Zhang C, Wang P, Li N, Li W, Liu H, Zhang S, Hu G, Yu Z, Ma RC, Chan JC, Yang X*. Plasma levels of alanine aminotransferase in the first trimester identify high risk Chinese women for gestational diabetes.Sci Rep. 2016 Jun 6;6:27291. doi: 10.1038/srep27291. (2-y IF: 4.259; 5-y IF: 4.847).
26.Leng J#, Liu G, Zhang C, Xin S, Chen F, Li B, Tian H, Yu Z, Tuomilehto J, Hu G, YangX*. Physical activity, sedentary behaviors and risk of gestational diabetes mellitus in Chinese pregnant women. Eur J Endocrinol. 2016 Jun;174(6):763-73. doi: 10.1530/EJE-15-1103. (2-y IF:4.101; 5-y IF: 4.142)
27.Wei F#, Sun N#, Cai C#, Feng S#, Tian J, Shi W, Xu W, Wang Y*, Yang X*, Li WD*.Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study. J Transl Med. 2016 Apr 30;14(1):110. doi: 10.1186/s12967-016-0866-0. (2-y IF: 3.786; 5-y IF: 4.261)
28.Gu W#, Ren Y#, Ji L, Hong T*, Mu Y, Guo L, Li Q, Tian Q, Yang X*.Non-linear associations of risk factors with hypoglycaemia among Chinese patients with type 2 diabetes. J Diabetes Complications.2016 Apr;30(3):462-8. doi: 10.1016/j.jdiacomp.2015.12.024. Epub 2015 Dec 29. (2-y IF: 2.734; 5-y IF: 2.814)
29.Huo X#,Gao L#, Guo L#, Xu W, Wang W, Zhi X, Li L, Ren Y, Qi X, Sun Z,Li W, Ji Q, Ran X, Su B, Hao C, Lu J, Guo X, Zhuo H, Zhang D, Pan C, Weng J,Hu D, Yang X*, Ji L*. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016 Feb;4(2):115-24. doi: 10.1016/S2213-8587(15)00508-2. (2-y IF: 19.742; 5-y IF: 19.337)
30.Li Y#, Mu Y#, Ji Q, Huang Q, Kuang H, Ji L*, Yang X*. Hypoglycemia, Abnormal Lipids and Cardiovascular Disease among Chinese with Type 2 Diabetes. Biomed Res Int. 2015;2015:862896. DOI: 10.1155/2015/862896. (2-y IF: 2.134; 5-y IF: 2.149)
31.Pan L, Leng J, Liu G, Zhang C, Liu H, Li M, Tan L, Tian H, Chan JC, Hu G, Yu Z, Yang X*. Pregnancy outcomes of Chinese women with gestational diabetes mellitus defined by the IADPSG’s but not by the 1999 WHO’s criteria.Clin Endocrinol (Oxf). 2015 Nov;83(5):684-93. 22 APR 2015. DOI: 10.1111/cen.12801. (2-y IF: 3.487; 5-y IF: 3.469)
32.Zhang C, Li Y, Wang L, Sun S, Liu G, Leng J, Guo J, Lv L, Li W, Zhang C, Hu G, Yu Z, Yang X*.ABO blood groups and gestational diabetes mellitus: a prospective population-based study in Tianjin, China.Diabetes Metab Res Rev. 2015 Sept; 31(6): 627-37. doi: 10.1002/dmrr.2650. [Epub ahead of print](2-y IF: 3.064; 5-y IF: 3.461)
33.Leng J, Shao P, Zhang C, Tian H, Zhang F, Zhang S, Dong L,Li L, Yu Z, Chan JC, Hu G, Yang X*. Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China. PLoS One. 2015 Mar 23;10(3):e0121029. doi: 10.1371/journal.pone.0121029. eCollection 2015. (2-y IF: 3.057; 5-y IF: 3.535)
34.Yang X#,*, Lee HM, Chan JC#,*. Drug-Subphenotype Interactions for Cancer in Type 2 Diabetes. Nat Rev Endocrinol. 2015 Jun;11(6):372-379. doi: 10.1038/nrendo.2015.37. Epub 2015 Mar 24. (2-y IF: 15.432; 5-y IF: 14.125)
35.Guo XH#, Weng JP#, Lu JM, Yang WY, Jia WP, Zou DJ, Zhou ZG, Zhu D, Ji QH, Shi LX, Ji LN*,, Yang XL*.Determinants of Poor Glycemic Control in Chinese Men with Type 2 Diabetes: A Cross Sectional Survey of 15427 Men in 77 Tertiary Hospitals in China. International Journal of Diabetes in Developing Countries. 2015;35(4):488-492. DOI: 10.1007/s13410-015-0322-3.(2-y IF: 0.366; 5-y IF: 0.494)
36.Li L#, Ji LN#, Guo XH,Ji QH,Gu WJ,Zhi XY,Li X,Kuang HY,Su BL,Yan JH,Yang XL*.Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 Diabetes.J Diabetes Complications.2015 Jan-Feb;29(1):32-7. doi: 10.1016/j.jdiacomp.2014.08.010. Epub 2014 Sep 3.(2-y IF: 2.955; 5-y IF: 2.732)
37.Yang X*, Tian H, Zhang F, Zhang C, Li Y, Leng J, Wang L, Liu G, Dong L, Yu Z, Hu G, Chan JC.A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes.J Transl Med. 2014 Oct 28;12:290. doi: 10.1186/s12967-014-0290-2. (2-y IF: 3.930; 5-y IF:4.126)
38.Lu J#, Weng J#, Gu W, GuoX, Yang W, Zou D, Zhou Z, Zhu D, Ji Q, Ji L*, Yang X*. Non-Pharmaceutical Factors for Poor Glycaemic Control in 13970 Chinese Women with Drug-Treated Type 2 Diabetes: A Cross Sectional Survey in 77 Tertiary Hospitals in Four Chinese Cities. Patient Preference and Adherence. 2014;8:1161-7 (2-y IF: 1.676; 5-y IF:1.721)
39.Ji L#,* Weng J#, Lu J, Guo X, Yang W, Jia W, Zou D, Zhou Z, Zhu D, Ji Q, Shi L, Yang X*.Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China.J Endocrinol Invest. 2014;37(9): 843-852. DOI: 10.1007/s40618-014-0115-4. (2-y IF: 1.448; 5-y IF:1.684)
40.Yang X*, Wang Y, Luk AO, So WY, Ma RC, Kong AP, Xu G, Chan JC*.Renin Angiotensin System Inhibitors May Attenuate Low LDL Cholesterol-Related Cancer Risk in Type 2 Diabetes. Diabetes Metab Res Rev 2014 Jul;30(5):415-23. doi: 10.1002/dmrr.2504. (2-y IF: 3.553; 5-y IF:3.416)
41.Kong AP#,*, Yang X#, Luk A, Cheung KK, Ma RC, So WY, Ho CS, Chan MH, Ozaki R, Chow CC, Brown N, Chan JC*. Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry. BMC Endocrine Disorders 2014 Jun 13;14(1):48. [Epub ahead of print]. (2-y IF: 1.710; 5-y IF:2.187)
42.Kong AP#, Yang X#, So WY, Luk A, Ma RC, Ozaki R, Cheung KK, Lee HM, Yu L, Xu G, Chow CC, Chan JC*. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes. BMC Medicine 2014 May 13;12(1):76. doi: 10.1186/1741-7015-12-76. (2-y IF: 7.356; 5-y IF:7.770)
43.Yang XL*, Kong AP, Luk A, Ozaki R, Ko GTC, Ma RCW, Chan JCN*, So WY. Validation of methods to control for immortal time bias in pharmacoepidemiological analysis of RAS inhibitors in Type 2 diabetes. Journal of Epidemiology 2014;24(4):267-73. DOI: http://dx.doi.org/10.2188/jea.JE20130164. (2-y IF: 3.022; 5-y IF:2.592)
44.Kong AP#,*, Yang XL#, Luk A, Ma RCW, So WY, Ozaki R, Ting R, Cheung K, Ho CS, Chan MH,Chow CC, Chan JCN. Severe hypoglycaemia identifies vulnerable patients with Type 2 diabetes at risk of premature death and all-site cancer: the Hong Kong diabetes registry. Diabetes Care 2014 Apr;37(4):1024-31. doi: 10.2337/dc13-2507. Epub 2014 Feb 10. (2-y IF: 8.420; 5-y IF:8.569)
45.Weng J#,*, Yang X#,*.Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications.J Diabetes. 2014 Jan;6(1):30-2. doi: 10.1111/1753-0407.12082. Epub 2013 Sep 18. (2-y IF: 1.932; 5-y IF:2.381)
PhD students: 3 graduated & 1 under supervision;
Master degree students: 9 graduated & 4 under supervision;
Recruits students specialized
Epidemiology
Membership of Academic Society
2017- | Deputy Director Member, Epidemiology Specialty Committee, Tianjin Heart Association |
2016- | Deputy Director Member, Tianjin Clinical Epidemiology Association |